Update on non-executive director appointment
Update on non-executive director appointment
September 30, 2019
Download full announcement
Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that it expects to appoint an additional non-executive director and healthcare industry veteran within the coming weeks.
A qualified candidate has been identified to the Company and the process of completing regulatory due diligence is nearing completion. Further announcements will be made at the appropriate time.
Enquiries
Renalytix AI plc | www.renalytixai.com |
James McCullough, CEO | Via Walbrook PR or Tel: +1 646 397 3970 |
Stifel (Nominated Adviser & Joint Broker) | Tel: 020 7710 7600 |
Alex Price / Jonathan Senior / Ben Maddison (Investment Banking) |
|
N+1 Singer (Nominated Adviser & Broker) | Tel: 020 7496 3000 |
Aubrey Powell / James White / George Tzimas (Corporate Finance) Tom Salvesen / Mia Gardner (Corporate Broking) |
|
Walbrook PR Limited | Tel: 020 7933 8780 renalytix@walbrookpr.com |
Paul McManus Lianne Cawthorne |
Mob: 07980 541 893 07584 391 303 |